Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/35938
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLOIX, Melanie-
dc.contributor.authorBOGIE, Jeroen-
dc.contributor.authorHENDRIKS, Jerome-
dc.contributor.authorHAIDAR, Mansour-
dc.date.accessioned2021-11-29T16:24:27Z-
dc.date.available2021-11-29T16:24:27Z-
dc.date.issued2021-
dc.date.submitted2021-10-28T08:01:37Z-
dc.identifier.citationTrends in endocrinology and metabolism, 32 (11) , p. 941 -951-
dc.identifier.urihttp://hdl.handle.net/1942/35938-
dc.description.abstractLipophagy is the process of selective degradation of lipid droplets (LDs) by autophagy. Several studies have highlighted the importance of lipophagy in regulating cellular lipid levels in various tissues and disease conditions. In recent years, disruption of autophagy and accumulation of LDs have been reported as pathological hallmarks in several neurodegenerative and neuroinflammatory diseases, raising the question whether lipophagy is a process that is important in the progression of these disorders. This supports the growing interest in lipid metabolism as a major player in neurodegeneration, and the emerging understanding of several neurological pathologies as not only proteinopathies but also lipidopathies. In this review we discuss the importance of lipophagy in the most common central nervous system diseases. We examine the latest evidence for the reported interplay between abnormalities in lipid accumulation and autophagy, and propose lipophagy as a potentially important mechanism in neurodegeneration.-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE LONDON-
dc.rights© 2021 Elsevier Ltd. All rights reserved.-
dc.titleLipophagy: a new player in CNS disorders-
dc.typeJournal Contribution-
dc.identifier.epage951-
dc.identifier.issue11-
dc.identifier.spage941-
dc.identifier.volume32-
local.format.pages11-
local.bibliographicCitation.jcatA1-
dc.description.notesHendriks, JJA (corresponding author), Hasselt Univ, Biomed Res Inst, Dept Immunol & Infect, Diepenbeek, Belgium.-
dc.description.notesjerome.hendriks@uhasselt.be-
local.publisher.place84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedReview-
dc.identifier.doi10.1016/j.tem.2021.08.010-
dc.identifier.isiWOS:000707636500010-
local.provider.typewosris-
local.uhasselt.uhpubyes-
local.description.affiliation[Haidar, Mansour; Loix, Melanie; Bogie, Jeroen F. J.; Hendriks, Jerome J. A.] Hasselt Univ, Biomed Res Inst, Dept Immunol & Infect, Diepenbeek, Belgium.-
local.uhasselt.internationalno-
item.fullcitationLOIX, Melanie; BOGIE, Jeroen; HENDRIKS, Jerome & HAIDAR, Mansour (2021) Lipophagy: a new player in CNS disorders. In: Trends in endocrinology and metabolism, 32 (11) , p. 941 -951.-
item.fulltextNo Fulltext-
item.validationecoom 2022-
item.contributorLOIX, Melanie-
item.contributorBOGIE, Jeroen-
item.contributorHENDRIKS, Jerome-
item.contributorHAIDAR, Mansour-
item.accessRightsClosed Access-
crisitem.journal.issn1043-2760-
crisitem.journal.eissn1879-3061-
Appears in Collections:Research publications
Show simple item record

WEB OF SCIENCETM
Citations

18
checked on May 1, 2024

Page view(s)

48
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.